WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma

被引：0

作者：

Nicholas Coupe

Lina Guo

Esther Bridges

Leticia Campo

Olivia Espinosa

Richard Colling

Andrea Marshall

Ashwin Nandakumar

Ruud van Stiphout

Francesca M. Buffa

Pippa G. Corrie

Mark R. Middleton

Valentine M. Macaulay

机构：

[1] University of Oxford,Department of Oncology

[2] Oxford University Hospitals NHS Foundation Trust,Department of Oncology, Oxford Cancer and Haematology Centre

[3] Churchill Hospital,Department of Cellular Pathology

[4] Oxford University Hospitals NHS Foundation Trust,Warwick Clinical Trials Unit, Division of Health Sciences

[5] John Radcliffe Hospital,Nuffield Department of Surgical Sciences

[6] University of Warwick,Department of Oncology

[7] University of Oxford,undefined

[8] Cambridge University Hospitals NHS Foundation Trust,undefined

[9] Addenbrooke’s Hospital,undefined

来源：

Cellular Oncology | 2023年 / 46卷

关键词：

Melanoma; BRAF; Bevacizumab; ROR2; WNT5A;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：391 / 407

页数：16

共 50 条

[11] AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis
Mcree, Siobhan K.
Bayer, Abraham L.
Pietruska, Jodie
Tsichlis, Philip N.
Hinds, Philip W.
CANCERS, 2023, 15 (20)
[12] Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma
Wang, Lei
Yang, Dong
Wang, Ying-Hou
Li, Xi
Gao, Hong-Ming
Lv, Jun-Yuan
Wang, Lei
Xin, Shi-Jie
TUMOR BIOLOGY, 2016, 37 (05) : 6085 - 6090
[13] The role of WNT5A and Ror2 in peritoneal membrane injury
Padwal, Manreet
Liu, Limin
Margetts, Peter J.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (06) : 3481 - 3491
[14] Prognostic Significance of Ror2 and Wnt5a Expression in Medulloblastoma
Lee, Seung Eun
Lim, So Dug
Kang, So Young
Suh, Sang Bum
Suh, Yeon-Lim
BRAIN PATHOLOGY, 2013, 23 (04) : 445 - 453
[15] Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups
Kim, Yuil
Hong, Mineui
Do, In-Gu
Ha, Sang Yun
Lee, Dakeun
Suh, Yeon-Lim
PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (12) : 963 - 972
[16] miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
Liu, Szu-Mam
Lu, Jean
Lee, Hoong-Chien
Chung, Feng-Hsiang
Ma, Nianhan
ONCOTARGET, 2014, 5 (19) : 9444 - 9459
[17] Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition
Sakamoto, Taiki
Kawano, Shintaro
Matsubara, Ryota
Goto, Yuichi
Jinno, Teppei
Maruse, Yasuyuki
Kaneko, Naoki
Hashiguchi, Yuma
Hattori, Taichi
Tanaka, Shoichi
Kitamura, Ryoji
Kiyoshima, Tamotsu
Nakamura, Seiji
ORAL ONCOLOGY, 2017, 69 : 15 - 25
[18] Wnt5a/Ror2-induced upregulation of xPAPC requires xShcA
Feike, Ann Caroline
Rachor, Klara
Gentzel, Marc
Schambony, Alexandra
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 400 (04) : 500 - 506
[19] Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma
Park, Byung-Sun
Jeon, Heeju
Kim, Yeonseo
Kwon, Haejin
Choi, Ga-Eun
Chi, Sung-Gil
Park, Hyun-Mee
Lee, Hyunbeom
Kim, Tackhoon
MOLECULAR CANCER, 2024, 23 (01)
[20] Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma
Lu, Bei-Ji
Wang, Yun-Qing
Wei, Xue-Jie
Rong, Liang-Qun
Wei, Dong
Yan, Chang-Ming
Wang, Deng-Jie
Sun, Jun-Ying
MOLECULAR MEDICINE REPORTS, 2012, 5 (04) : 1033 - 1036

← 1 2 3 4 5 →